Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resistant Starch in COVID-19
NCT04342689Phase 3Terminated
- Sponsor
- Yale University
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of resistant starch in coronavirus disease 2019 (COVID-19), sponsored by Yale University. Started Jun 2020; status: terminated.
02
Drugs
resistant starch
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04342689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342689.